1. UnitedHealth stock showed rally potential exceeding 30% in several key years. 2. Shares declined from 2024 peaks due to high medical costs and regulatory changes. 3. Projected growth recovery in 2026 could attract investors and boost valuations. 4. Optum's success in revenue growth and margin enhancement are promising. 5. Historical sell-offs reveal significant stock vulnerability during market downturns.